Frailty was a significant predictor of severe outcomes and hospitalization characteristics in older adults hospitalized with RSV infection.

Fiancé couple Annie Suwan and David Toborowsky have been especially emotional as their infant daughter, Minthirarad, is ...

With the 2025 influenza season starting earlier than usual, the NICD urges South Africans to stay vigilant against seasonal viruses like flu and RSV. Learn about the symptoms, preventive measures, and ...

Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...

In April, the CDC’s influential Advisory Committee on Immunization Practices recommended expanding RSV vaccination to ...

RSV, or Respiratory Syncytial Virus, is a common virus that primarily affects the respiratory tract, often causing cold-like symptoms such as coughing, sneezing, and runny nose.

Gilead has blamed the low rate of respiratory syncytial virus infections last season for ending two midstage trials of obeldesivir.

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially deadly RSV.

CDC advisers recommend Merck's Enflonsia to protect babies from RSV, addressing the leading cause of infant hospitalization ...

The RSV drug in question, clesrovimab, is recommended for infants younger than 8 months. It was approved in early June, making it the second FDA-approved RSV preventive therapy for young children.

The FDA expanded the approval of Moderna’s RSV vaccine, extending the license to include more adults and giving the company a welcome win.